The global foam dressing market size is expected to reach USD 2.52 billion by 2030, expanding at a CAGR of 4.73% from 2024 to 2030, according to a new report by Grand View Research, Inc. A few of the key drivers propelling the market growth include an increase in surgical cases, a rapidly aging population, and an increase in the number of diabetes patients. For instance, according to the World Economic Forum, the current population of Japanese people above 65 years of age is 25% of the total population. This number is further expected to rise to 40% by 2060. Older people are more likely to sustain wounds, thus, the market for foam dressing is expected to grow throughout the forecast period.
An increase in the number of obese/overweight people is another fueling factor of the market. For instance, according to an article by Sage Journals & Indian Academy of Neurosciences, 2021, the number of obese people in India is estimated to be 135 million. Similarly, as per the Obesity Evidence Hub, two-thirds of the Australian people, i.e., 35.6% are overweight, whereas, 31.3% are expected to be obese. These situations are anticipated to raise demand for bariatric treatments and other related surgeries, driving the growth of the market over the anticipated time frame.
Additionally, the industry is anticipated to grow in the upcoming years with the launch of the COVID-19 vaccine and the relaxation of lockdown restrictions. It is anticipated that many elective procedures will be performed that were delayed. Moreover, many top producers are engaged in strategic activities including new launches, partnerships, and geographic expansion that could enable them to profit from the rising demand for foam dressing products during the projection period. For instance, in February 2022, Medline Industries announced the launch of a new version of its foam dressing Optifoam Gentle EX Foam Dressing. This is specially designed to displace the pressure whenever used with a pressure injury prevention protocol. Thus, similar initiatives by other market players are anticipated to boost market growth during the post-pandemic time.
Request a free sample copy or view the report summary: Foam Dressing Market Report
Based on type, the adhesive foam dressing segment dominated the market and accounted for a revenue share of 56.59% in 2023, owing to an increase in the number of high exudate wound patients
Based on application, the chronic wound application segment accounted for a revenue share of 59.83% in 2023 and is leading the market
Based on end-use, the hospital segment dominated the market, due to an increase in surgical site infections among hospital patients. On the other hand, during the projected period, the home healthcare segment is anticipated to witness the fastest CAGR over the forecast period
North America dominated the market and accounted for the highest revenue share of 45.46% in 2023 owing to the increasing number of diabetic patients, rise in the number of obese population, and technological advancements
Grand View Research has segmented the global foam dressing market based on type, application, end-use, and region:
Foam Dressing Type Outlook (Revenue, USD Million, 2018 - 2030)
Adhesive Foam Dressing
Non-adhesive Foam Dressing
Foam Dressing Application Outlook (Revenue, USD Million, 2018 - 2030)
Acute Wounds
Surgical & Traumatic Wounds
Burns
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Foam Dressing End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Home Healthcare
Others
Foam Dressing Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Foam Dressing Market
3M
Coloplast Corp.
Medline Industries
Smith & Nephew
Cardinal Health
ConvaTec Group PLC
Derma Sciences Inc. (Integra LifeSciences)
Ethicon (Johnson & Johnson)
McKesson Corporation
Molnlycke Health Care AB
"The quality of research they have done for us has been excellent..."